Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (2014 - 2022)

Corbus Pharmaceuticals Holdings' Capital Expenditures history runs 9 years deep, the most recent figure standing at $13449.0 for Q1 2022.

• In Q1 2022, Capital Expenditures changed N/A year-over-year to $13449.0; the TTM figure through Dec 2022 stood at $13449.0 (down 82.08% YoY), while the FY2022 annual figure was $13449.0, down 75.17% from the prior year.
• Capital Expenditures was $13449.0 for Q1 2022 at Corbus Pharmaceuticals Holdings, down from $54172.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.3 million in Q4 2019 to a low of -$1.2 million in Q2 2018.
• Historically, Capital Expenditures has averaged $235415.8 across 5 years, with a median of $57173.0 in 2018.
• Biggest YoY gain for Capital Expenditures was 3063.92% in 2018; the steepest drop was 3061.65% in 2018.
• A 5-year view of Capital Expenditures shows it stood at -$91528.0 in 2018, then surged by 1511.01% to $1.3 million in 2019, then slumped by 104.03% to -$52086.0 in 2020, then soared by 204.0% to $54172.0 in 2021, then tumbled by 75.17% to $13449.0 in 2022.
• The last three Capital Expenditures figures came in at $13449.0 (Q1 2022), $54172.0 (Q4 2021), and -$52086.0 (Q4 2020), per Business Quant data.